COVID-19 pandemic Moderna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine. Moderna begins Phase 2 trial for bivalent COVID-19 booster for 'fall booster season' © MarketWatch Sources: BNN Bloomberg MarketWatch
